Article Details

Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of Triple Combination ...

Retrieved on: 2021-02-26 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of Triple Combination .... View article details on hiswai:

Excerpt

February 26, 2021 07:30 ET | Source: Arbutus Biopharma Corporation; Assembly Biosciences, Inc. Trial will evaluate Assembly's core inhibitor candidate ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up